Stability of Lisinopril Syrup (2 mg/mL) Extemporaneously Compounded from Tablets
Author(s): Rose Deidra J, Webster Andrew A, English Brett A, McGuire J Michael
Issue: Sep/Oct 2000 - Compounding for Immune System Disorders
View All Articles in Issue
Page(s): 398-399
Download in electronic PDF format for $65
Abstract: The stability of lisinopril syrup (2 mg/mL) extemporaneously compounded from
tablets was investigated. Zestril® tablets (Lot CSC201, Zeneca Pharmaceuticals,
Wilmington, Del) were crushed, dissolved in water, filtered, and diluted with syrup
NF to a final nominal concentration of 2 mg/mL. The solution was then equally
divided among amber-colored prescription bottles and was stored at 5°C and 23°C.
During the 30-day study period, samples were extracted by means of a water:methanol
mix, and the concentration of lisinopril was determined by a stability-indicating, highperformance
liquid chromatography assay procedure. Stability was also determined
by pH measurements and visual inspection for color or clarity change. Over the 30-
day study period, the percentage of the initial lisinopril concentration remained
between 99.42% ± 0.19% and 95.68% ± 1.5% for the 5°C samples and 98.83% ± 0.46%
and 96.48% ± 0.62% for the 23°C samples.
Related Keywords:
lisinopril syrup, stability, liquid lisinopril, storage
Related Articles from IJPC |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
Stability of Lisinopril Syrup (2 mg/mL) Extemporaneously Compounded from Tablets
Rose Deidra J, Webster Andrew A, English Brett A, McGuire J Michael
|
Sep/Oct 2000
Pg. 398-399
|
Lisinopril 1-mg/mL Oral Liquid
Allen Loyd V Jr
|
Jul/Aug 2006
Pg. 302
|
The Stability of Lisinopril as an Extemporaneous Syrup
Webster Andrew A, English Brett A, Rose Deidra J
|
Sep/Oct 1997
Pg. 352-353
|
Lisinopril 1-mg/mL, Sodium Citrate, and Citric Acid Oral Liquid
Allen Loyd V Jr
|
Sep/Oct 2006
Pg. 386
|
Lisinopril 1 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Jul/Aug 2020
Pg. 318
|
Stability of Allopurinol, Amitriptyline Hydrochloride, Carbamazepine, Domperidone, Isoniazid, Ketoconazole, Lisinopril, Naproxen, Paracetamol (Acetaminophen), and Sertraline Hydrochloride in SyrSpend SF PH4 Oral Suspensions
Polonini Hudson C, Loures Sharlene, de Araujo Edson Peter, Brandão Marcos Antônio F, Ferreira Anderson O
|
Sep/Oct 2016
Pg. 426-434
|
Oral Liquid Vehicles, Featured Excipient:
Allen Loyd V Jr
|
Jan/Feb 2001
Pg. 65-67
|
pH Stability of Injectable Fentanyl, Bupivacaine, or Clonidine Solution or a Ternary Mixture in 0.9% Sodium Chloride in Two Types of Polypropylene Syringes
Jappinen Annaliisa L, Kokki H, Rasi A S, Naaranlahti Toivo J
|
Nov/Dec 2002
Pg. 471-474
|
Stability of Oseltamivir Phosphate in SyrSpend SF, Cherry Syrup, and SyrSpend SF (For Reconstitution)
Voudrie Mark A II, Allen D Brett
|
Jan/Feb 2010
Pg. 82-85
|
Stability of Verapamil Hydrochloride in SyrSpend SF Compared to Sorbitol Containing Syrup and Suspending Vehicles
Voudrie Mark A, Alexander Bridget, Allen D Brett
|
May/Jun 2011
Pg. 255-258
|